BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 27094534)

  • 1. CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos.
    Kouranova E; Forbes K; Zhao G; Warren J; Bartels A; Wu Y; Cui X
    Hum Gene Ther; 2016 Jun; 27(6):464-75. PubMed ID: 27094534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
    Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
    ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress of application and off-target effects of CRISPR/Cas9.
    Zheng W; Gu F
    Yi Chuan; 2015 Oct; 37(10):1003-10. PubMed ID: 26496752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified pipelines for genetic engineering of mammalian embryos by CRISPR-Cas9 electroporation†.
    Miao D; Giassetti MI; Ciccarelli M; Lopez-Biladeau B; Oatley JM
    Biol Reprod; 2019 Jul; 101(1):177-187. PubMed ID: 31095680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precise Genome Editing of Drosophila with CRISPR RNA-Guided Cas9.
    Gratz SJ; Harrison MM; Wildonger J; O'Connor-Giles KM
    Methods Mol Biol; 2015; 1311():335-48. PubMed ID: 25981484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CRISPR/Cas9-based genome editing systems and the analysis of targeted genome mutations in plants].
    Ma XL; Liu YG
    Yi Chuan; 2016 Feb; 38(2):118-25. PubMed ID: 26907775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of site-specific mutations in the rat genome via CRISPR/Cas9.
    Guan Y; Shao Y; Li D; Liu M
    Methods Enzymol; 2014; 546():297-317. PubMed ID: 25398346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
    Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
    J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Specificity of the CRISPR/Cas9 System.
    Tasan I; Zhao H
    ACS Synth Biol; 2017 Sep; 6(9):1609-1613. PubMed ID: 28911233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.
    Jo YI; Suresh B; Kim H; Ramakrishna S
    Biochim Biophys Acta; 2015 Dec; 1856(2):234-43. PubMed ID: 26434948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient RNA/Cas9-mediated genome editing in Xenopus tropicalis.
    Guo X; Zhang T; Hu Z; Zhang Y; Shi Z; Wang Q; Cui Y; Wang F; Zhao H; Chen Y
    Development; 2014 Feb; 141(3):707-14. PubMed ID: 24401372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editing the Mouse Genome Using the CRISPR-Cas9 System.
    Williams A; Henao-Mejia J; Flavell RA
    Cold Spring Harb Protoc; 2016 Feb; 2016(2):pdb.top087536. PubMed ID: 26832693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insertional Mutagenesis by CRISPR/Cas9 Ribonucleoprotein Gene Editing in Cells Targeted for Point Mutation Repair Directed by Short Single-Stranded DNA Oligonucleotides.
    Rivera-Torres N; Banas K; Bialk P; Bloh KM; Kmiec EB
    PLoS One; 2017; 12(1):e0169350. PubMed ID: 28052104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 as tool for functional study of genes involved in preimplantation embryo development.
    Kwon J; Namgoong S; Kim NH
    PLoS One; 2015; 10(3):e0120501. PubMed ID: 25775469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-viral delivery of the CRISPR/Cas system: DNA
    Lin Y; Wagner E; Lächelt U
    Biomater Sci; 2022 Mar; 10(5):1166-1192. PubMed ID: 35103261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
    Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
    Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning-free CRISPR.
    Arbab M; Srinivasan S; Hashimoto T; Geijsen N; Sherwood RI
    Stem Cell Reports; 2015 Nov; 5(5):908-917. PubMed ID: 26527385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9 Gene Targeting in Primary Mouse Bone Marrow-Derived Macrophages.
    Bailis W
    Methods Mol Biol; 2020; 2097():223-230. PubMed ID: 31776929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9.
    Gundry MC; Brunetti L; Lin A; Mayle AE; Kitano A; Wagner D; Hsu JI; Hoegenauer KA; Rooney CM; Goodell MA; Nakada D
    Cell Rep; 2016 Oct; 17(5):1453-1461. PubMed ID: 27783956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of knockout mice by DNA microinjection of various CRISPR/Cas9 vectors into freeze-thawed fertilized oocytes.
    Nakagawa Y; Sakuma T; Sakamoto T; Ohmuraya M; Nakagata N; Yamamoto T
    BMC Biotechnol; 2015 May; 15():33. PubMed ID: 25997509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.